RAAS inhibitors are also commonly prescribed to hypertensive patients with diabetes or chronic kidney disease (CKD) to reduce urinary albumin excretion and prevent or delay the onset of diabetic nephropathy and end-stage renal disease (ESRD) [11–13]. The gene discussed is ALB; the disease is diabetes mellitus.